M3-Brigade Acquisition V Corp. - Class A Ordinary shares

M3-Brigade Acquisition V Corp. - Class A Ordinary shares Share · KYG632121078 · MBAV (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of M3-Brigade Acquisition V Corp. - Class A Ordinary shares
No Price
01.05.2026 20:00
Current Prices from M3-Brigade Acquisition V Corp. - Class A Ordinary shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MBAV
USD
01.05.2026 20:00
10,79 USD
0,02 USD
+0,19 %
IEXG: IEX
IEX
MBAV
USD
29.04.2026 19:50
10,81 USD
-
Company Profile for M3-Brigade Acquisition V Corp. - Class A Ordinary shares Share
M3-Brigade Acquisition V Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. M3-Brigade Acquisition V Corp. was incorporated in 2024 and is based in New York, New York.

Company Data

Name M3-Brigade Acquisition V Corp. - Class A Ordinary shares
Company M3-Brigade Acquisition V Corp. Class A Ordinary shares
Symbol MBAV
Website https://www.m3-brigade.com
Primary Exchange XNAS NASDAQ
ISIN KYG632121078
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Reeve Rivas Collins
Market Capitalization 388 Mio
Country Cayman Islands
Currency USD
Employees -
Address 1700 Broadway, New York City

Ticker Symbols

Name Symbol
NASDAQ MBAV
More Shares
Investors who hold M3-Brigade Acquisition V Corp. - Class A Ordinary shares also have the following shares in their portfolio:
AXM Pharma, Inc.
AXM Pharma, Inc. Share
GOLDMAN SACHS 17/22 FLR
GOLDMAN SACHS 17/22 FLR Bond